| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |